Replies to post #150445 on Biotech Values

[pollyvonwog]

Moreover, Teva does not exactly have a history of playing straight with its regulatory disclosures to investors; Lovenox is a case in point.

To be fair, wasn't this more a symptom of TEVA's previous leadership?

Also, whatever happened with those bets you had with various posters here for dinner if TEVA didn't get approval?